Medical/Pharmaceuticals

China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity

HAIKOU, China, May 14, 2026 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals company in China, today announced that, in view of the unusual market activity in the common stock of China Pharma on May 1...

2026-05-14 20:56 5421

VARON Celebrates Older Americans Month by Supporting Healthy Aging and Independence

NEW YORK, May 14, 2026 /PRNewswire/ -- This May, in honor of Older Americans Month, VARON , a leading provider of oxygen and respiratory care so...

2026-05-14 19:06 1940

Applications Open for Second Annual Asia-Pacific Global Health Innovation Hackathon on Maternal & Child Nutrition

12 teams, 48 Hours. Innovating for a healthier, more equitable Asia-Pacific SINGAPORE, May 14, 2026 /PRNewswire/ -- Applications are now open for the second annual Asia-Pacific Global Health Innovation Hackathon, to be held in Singapore on 18–19 September 2026. Jointly co-hosted by two SingHealth...

2026-05-14 17:28 4581

So-Young to Report First Quarter 2026 Financial Results on May 22, 2026

BEIJING, May 14, 2026 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that it will report its financial results for the first...

2026-05-14 17:00 2494

Breakthrough skin-tightening device XERF™ arrives in Australia

The new radiofrequency treatment, XERF, is designed to target multiple layers of the skin while prioritizing patient comfort. SYDNEY, May 14, 2026 /PRNewswire/ -- Cynosure Lutronic's XERF is a radiofrequency-based treatment designed to tighten and revitalise skin without the need for needles, nu...

2026-05-14 16:50 3213

Wellcome launches world's largest global prize for mental health science

* The prize, in partnership with Nature, will celebrate breakthroughs in mental health science. It aims to accelerate translation, influence policy and transform lives * This award champions new pharmacological, psychological, social and digital interventions from around the world * The ...

2026-05-14 16:00 2605

SingPost and Fullerton Health to Collaborate on Healthcare Logistics and Last-Mile Medical Delivery

SINGAPORE, May 14, 2026 /PRNewswire/ -- Singapore Post Limited ("SingPost") and Fullerton Healthcare Group Private Limited ("Fullerton Health") have today announced the signing of a Memorandum of Understanding ("MOU") to explore the co-development of a robust, integrated healthcare delivery ecosy...

2026-05-14 15:24 2586

GenesisCare and SeeTreat to bring personalised Offline Adaptive Monitoring to more than 40 radiation oncology centres across Australia

SYDNEY, May 14, 2026 /PRNewswire/ -- Leading Australian cancer care provider, GenesisCare, is pleased to be collaborating with SeeTreat to enable suitable cancer patients access to the latest technology in offline adaptive treatment assessment. SeeTreat's ART.1 software will be rolled out at Gene...

2026-05-14 15:00 3248

EBT Medical and NinaMED Announce US$13.75M Financing to Advance Licensed NiNA System® for Overactive Bladder

* US$13.75M financing completed to accelerate clinical pathway and global commercialisation * Establishment of NinaMED Pty Ltd, a new Australian medtech company * NinaMED Pty Ltd secures a license from EBT Medical for exclusive global rights to NiNA System®, a non‑invasive, at‑home OAB thera...

2026-05-14 13:03 2423

Singapore's First Immersive Installation on the Cycles of Intergenerational Harm Opens at One Punggol This May

Why Hurt Children Hurt Children invites Singaporeans to step inside The Black Box — a confrontational, compassionate experience addressing the emotional harm that passes silently from one generation to the next SINGAPORE, May 14, 2026 /PRNewswire/ -- EveryChild.SG, Singapore's movement for child...

2026-05-14 12:11 3269

MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control

- Achieved statistical significance versus standard-of-care (SOC) control across all key efficacy endpoints in the 52-week study - Japan Phase 3 results strengthen CARTISTEM's® global commercial prospects, with Japan biologics license application (BLA) scheduled for 2H 2026 SEOUL, South Korea and...

2026-05-14 10:30 3184

METiS TechBio, the World's First Publicly Listed AI-Powered Drug Delivery Company, Debuts on the Hong Kong Stock Exchange, "The SpaceX of Pharmaceuticals" Ushers in a New Era of Biopharmaceuticals

HONG KONG, May 13, 2026 /PRNewswire/ -- METiS TechBio (7666.HK), a tech-bio company focused on AI-powered nanodelivery innovation, today successfully listed on the Hong Kong Stock Exchange (HKEX), becoming the world's first publicly listed AI-powered drug delivery company and the first AI-powered...

2026-05-14 10:09 3070

Corti steps up its support for the next wave of healthcare startups as OpenAI pushes into the space and others retreat from Europe

As compliance pressure mounts in every major healthcare AI market, Corti launches its Startup Acceleration Program to help founders clear a €600,000 regulatory barrier and build on the vertical model that outscored OpenAI on its new healthcare benchmark COPENHAGEN, Denmark, May 14, 2026 /PRNewsw...

2026-05-14 00:30 3123

Elabscience® Launches Self-Developed PolyHRP-Streptavidin Conjugate for Low-Abundance Biomarker Detection in ELISA

HOUSTON, May 13, 2026 /PRNewswire/ -- Elabscience® Bionovation Inc. ("Elabscience®" or "the Company") today announced the launch of its self-developed PolyHRP-Streptavidin conjugate, a signal amplification reagent designed to improve enzyme-linked immunosorbent assay (ELISA) sensitivity for low-...

2026-05-14 00:00 2857

Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility

* The Riverview facility provides comprehensive services for active pharmaceutical ingredients (APIs) and high potency APIs (HPAPIs), including specialized solutions for payload-linkers. * This cutting-edge suite will significantly enhance the company's ability to support global payload-linke...

2026-05-13 22:45 3272

ZEISS expands ophthalmic surgical workflows in Mexico with COFEPRIS approval for ARTEVO 850 and MICOR 700

* Elevates digital visualization for surgeons - ZEISS ARTEVO 850 surgical microscope provides ophthalmic surgeons in Mexico with advanced 3D visualization and end-to-end workflow integration. * Minimizes risk and increases O.R. efficiency for cataract surgery - ZEISS MICOR 700 first hand-held...

2026-05-13 21:00 2885

NYSE Content Update: Global Medical Response to Go Public After $479 Million IPO

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 13, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins...

2026-05-13 20:59 3974

Department of Health - Abu Dhabi and Fred Hutchinson Cancer Center collaborate on cancer research and personalized prevention

ABU DHABI, UAE, May 13, 2026 /PRNewswire/ -- The Department of Health - Abu Dhabi (DoH), regulator of the healthcare sector in the emirate, together with the Abu Dhabi Public Health Center (ADPHC), today announced the execution of a Memorandum of Understanding ("MOU") with Fred Hutchinson Cancer ...

2026-05-13 20:23 2920

High-Trend International Group Announces Pricing of $15 Million Registered Direct Offering with Global Institutional Investors

NEW YORK, May 13, 2026 /PRNewswire/ -- High-Trend International Group (NASDAQ: HTCO) ("HTCO" or the "Company"), a global ocean transportation company, today announced that it has entered into securities purchase agreements with global institutional investors for the purchase and sale of 2,307,700...

2026-05-13 20:00 3832

Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.

LONDON, May 13, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in Ai-driven precision medicine, today announced a partnership with Synnovis, one of England's leading pathology providers, to bring liquid biopsy testing to lung and breast cancer patients across the U.K. as par...

2026-05-13 17:00 2588
1234567 ... 650